Hsbc Holdings PLC Raises Stake in HCA Healthcare, Inc. $HCA

Hsbc Holdings PLC lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 285,650 shares of the company’s stock after buying an additional 19,023 shares during the period. Hsbc Holdings PLC owned approximately 0.13% of HCA Healthcare worth $133,410,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Norges Bank purchased a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $1,262,513,000. Life Cycle Investment Partners Ltd purchased a new position in HCA Healthcare in the 4th quarter valued at $374,037,000. Viking Global Investors LP raised its position in HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after buying an additional 690,773 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in HCA Healthcare by 4,545.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after purchasing an additional 649,058 shares in the last quarter. Finally, Danske Bank A S purchased a new stake in shares of HCA Healthcare in the third quarter valued at approximately $115,530,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 0.1%

Shares of NYSE:HCA opened at $375.37 on Monday. The business has a fifty day simple moving average of $419.68 and a 200-day simple moving average of $468.81. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52. The company has a market cap of $83.27 billion, a P/E ratio of 12.91, a P/E/G ratio of 1.19 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter last year, the firm earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on HCA shares. Barclays lowered their price target on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Sanford C. Bernstein reduced their price target on shares of HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating on the stock in a report on Thursday, June 4th. Mizuho raised their price target on HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 25th. Wells Fargo & Company decreased their price objective on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a research note on Monday, April 27th. Finally, Weiss Ratings downgraded shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Fifteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $506.14.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.